Afib patients on low-dose DOACs experienced more bleeding in first 3 months, with high blood levels in 20%, per study in Blood Advances.
Atrial fibrillation (Afib) patients on low doses of blood thinners called direct oral anticoagulants (DOACs) faced more bleeding episodes during the first three months of treatment, with one in five patients having high blood levels of the medication, compared to those on standard doses, according to a study in Blood Advances. Afib affects up to 6 million people, increasing their stroke risk fivefold; doctors may prescribe lower doses to reduce bleeding risks.
June 06, 2024
3 Articles